Author

Spasenija Bradic

Observed name: S Bradic

Institution: Reckitt Benckiser (Germany)

Observed institutions: Reckitt Benckiser (Germany), Reckitt Benckiser (United Kingdom), Reckitt Benckiser Health Limited (United Kingdom)

ORCID: 0009-0006-7544-9736

Observed ORCID: 0009-0006-7544-9736

OpenAlex ID: A5087894548

Reducing Antibiotic Misuse through the Use of Point-of-Care Tests in Germany: A Survey of 1257 Medical Practices

2023 · Tina Peiter, Monika Haering, et al. · Healthcare · 4

Parent-Reported Satisfaction, Perceived Child Acceptance, and Ease of Administration of a Strawberry-Flavoured Ibuprofen Suspension for Children: A Cross-Sectional Survey of Experienced Users in Germany

2026 · Kerstin Weber, Spasenija Bradic, et al. · Journal of Market Access & Health Policy

Efficacy and safety of Xyloglucan (XG), pea protein and tannins (PPT), and Xylo-oligosaccharides (XOS) for diarrhoea-predominant irritable bowel syndrome: a randomised, crossover clinical trial

2025 · S Bradic, W Malik, et al. · Zeitschrift für Gastroenterologie

Efficacy of xyloglucan, pea protein and chia seed powder for patients with constipation-predominant irritable bowel syndrome: a randomised placebo-controlled trial

2025 · S Bradic, W Malik, et al. · Zeitschrift für Gastroenterologie

HSD113 Reducing Antibiotic Misuse Through the Use of Point-of-Care Tests in Germany – A Multicenter Study

2022 · T Peiter, M Haering, et al. · Value in Health

Works count: 5

Citation count: 4

H-index: 1

I10-index: